FLGR-242 vs Alpha-Klotho: Research Comparison and Sourcing Guide

FLGR-242 and Alpha-Klotho represent distinct biochemical targets in cellular regulation: FLGR-242 functions as a Follistatin-related regulatory peptide, whereas Alpha-Klotho operates as a transmembrane and soluble co-receptor in FGF23 signaling. PX1 Research supplies both compounds with verified USA synthesis, third-party HPLC/MS and endotoxin testing per lot, and same-day domestic shipping M–F from CA and AZ facilities.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

FLGR-242 and Alpha-Klotho represent distinct biochemical targets in cellular regulation: FLGR-242 functions as a Follistatin-related regulatory peptide, whereas Alpha-Klotho operates as a transmembrane and soluble co-receptor in FGF23 signaling. PX1 Research supplies both compounds with verified USA synthesis, third-party HPLC/MS and endotoxin testing per lot, and same-day domestic shipping M–F from CA and AZ facilities.

Reviewed by PX1 Research scientific team

Key takeaways

  • FLGR-242 and Alpha-Klotho are two distinct research peptides evaluated in longevity, metabolic regulation, and tissue homeostasis assays.
  • FLGR-242 is a specialized synthetic peptide designed to model the biological activity of endogenous Follistatin-like proteins.
  • Alpha-Klotho (often referred to simply as Klotho) is a single-pass transmembrane protein that can also be shed by membrane proteases to generate a functional soluble isoform circulating in biological fluids.
  • The primary functional difference when comparing flgr-242 vs alpha-klotho lies in their primary signaling cascades.

At a glance: Key differences for laboratory investigation

FLGR-242 and Alpha-Klotho are two distinct research peptides evaluated in longevity, metabolic regulation, and tissue homeostasis assays. While both compounds intersect in models examining cellular aging and tissue maintenance, their primary molecular targets, structural complexity, and signaling pathways are fundamentally different.

FLGR-242 is an engineered peptide derivative derived from research into Follistatin-like proteins, primarily investigated for its role in regulating specific growth factor pathways and cellular hypertrophy signaling in vitro.

Alpha-Klotho is a naturally occurring, multi-domain enzyme and transmembrane protein that acts as an essential co-receptor for Fibroblast Growth Factor 23 (FGF23), regulating phosphate homeostasis, oxidative stress pathways, and Wnt signaling cascades.

Researchers choosing between these targets must evaluate structural stability, specific assay requirements, and lot-to-lot purity verification. Evaluating both compounds side by side allows laboratories to optimize experimental protocols across cellular culture and preclinical rodent models.

What is FLGR-242 in preclinical research?

FLGR-242 is a specialized synthetic peptide designed to model the biological activity of endogenous Follistatin-like proteins. In structural studies, researchers focus on its modified peptide backbone, which is engineered for selective binding affinity and resistance to enzymatic degradation in vitro.

In cell culture models, investigators utilize FLGR-242 research documentation to analyze TGF-beta superfamily signaling modulation, specifically observing how sequence modifications influence myostatin and activin binding pathways without native full-length protein interference.

Preclinical data suggest that FLGR-242 provides a targeted mechanism for evaluating downstream protein synthesis and cellular hypertrophic pathways. When principal investigators order 10 mg vials of FLGR-242, they receive a refined compound optimized for stability in standard buffer systems.

What is Alpha-Klotho and how is it investigated?

Alpha-Klotho (often referred to simply as Klotho) is a single-pass transmembrane protein that can also be shed by membrane proteases to generate a functional soluble isoform circulating in biological fluids. In cellular biology, it functions as an obligate co-receptor required for high-affinity binding of FGF23 to its cognate receptors.

In experimental models, researchers examine the Alpha-Klotho research profile to analyze its enzymatic activity as a glucuronidase, its inhibition of insulin/IGF-1 signaling, and its protective effects against oxidative stress in renal and cardiovascular tissue cultures.

Because of its complex structural domains, sourcing high-purity recombinant or fragment peptides like Alpha-Klotho research grade requires rigorous batch verification to ensure proper tertiary folding and receptor affinity during long-term assay runs.

Mechanistic comparison: Molecular targets and signaling pathways

The primary functional difference when comparing flgr-242 vs alpha-klotho lies in their primary signaling cascades. FLGR-242 acts primarily as a localized ligand modulator targeting myostatin and activin receptors, influencing Smad2/3 phosphorylation and downstream transcriptional programs.

Conversely, Alpha-Klotho exerts broad endocrine and paracrine actions. As a membrane-bound co-receptor, it regulates phosphate balance via FGF23 binding. As a soluble circulating peptide, it interacts directly with cell surface receptors to suppress Wnt signaling, modulate ion channels (TRPV5/TRPC6), and enhance superoxide dismutase activity.

Consequently, research models focusing strictly on localized tissue growth, muscular signaling, or targeted peptide receptor interactions typically implement FLGR-242. Research models examining systemic aging mechanisms, renal function, or complex metabolic crosstalk rely on Alpha-Klotho.

Side-by-side criteria comparison

To assist laboratory personnel in selecting the appropriate peptide for specific assay protocols, the following criteria outline the operational and mechanistic differences between FLGR-242 and Alpha-Klotho:

• Primary Receptor Target: FLGR-242 targets TGF-beta superfamily ligands (ActRIIB/Myostatin axis); Alpha-Klotho targets FGFR1c/3c/4 (via FGF23 complexing) and cell surface Wnt/IGF-1 receptors.

• Structural Class: FLGR-242 is a synthetic peptide derivative; Alpha-Klotho is a recombinant protein/polypeptide isoform.

• Preclinical Evidence Base: FLGR-242 is investigated in localized muscle differentiation, cellular growth factor regulation, and extracellular matrix remodeling models. Alpha-Klotho is documented across renal homeostasis, neuroprotection, vascular calcification, and systemic longevity assays.

• Available Vial Packaging: FLGR-242 is typically supplied as lyophilized powder in 5 mg or 10 mg vials; Alpha-Klotho is packaged according to specific biological activity or molar concentration requirements.

• Handling and Stability: FLGR-242 demonstrates high stability upon reconstitution in sterile bacteriostatic water or saline; Alpha-Klotho requires precise pH control and temperature preservation to maintain tertiary conformation.

• Primary Study Contexts: FLGR-242 is utilized in high-throughput signaling assays and localized tissue studies; Alpha-Klotho is utilized in multi-system physiological assays and enzymatic activity panels.

In vitro and animal model assay design strategies

When designing comparative in vitro experiments, researchers must establish baseline controls appropriate for each compound's molecular weight and binding dynamics. FLGR-242 assays frequently measure reporter gene activity, Western blot phosphorylation states of Smad proteins, and protein accumulation metrics in skeletal muscle cell lines.

Alpha-Klotho assays generally involve measuring intracellular ROS production, phosphate transport across epithelial cell membranes, or competitive binding inhibition against FGF receptor complexes. Because soluble Alpha-Klotho exhibits pleiotropic cellular effects, assays must strictly control for background growth factor concentrations in culture media.

For comparative metabolic or cellular longevity screens, laboratories may cross-reference these peptides with other regulatory sequences in the complete PX1 Research catalog to build comprehensive multi-target screening panels.

Reconstitution, solubilization, and storage protocols

Proper reconstitutions are critical for maintaining peptide integrity and preventing batch-to-batch variance during experimental series. FLGR-242 should be reconstituted using sterile laboratory-grade water or buffered saline, reconstituted gently without vortexing, and aliquoted to avoid repeated freeze-thaw cycles.

Reconstitution of Alpha-Klotho requires careful attention to specific buffer pH and ionic strength as outlined in the lot-specific certificate of analysis. Due to its larger structure, aggressive agitation can cause denaturation or irreversible aggregation.

Both compounds are supplied as lyophilized powders and should be stored at -20°C or -80°C upon receipt. Short-term storage of working aliquots after reconstitution should be maintained at 4°C for duration specified by stable decay testing.

How to vet a peptide supplier: Red flags in research chemicals

Ensuring reproducibility in scientific literature requires sourcing peptides from transparent suppliers that publish verifiable quality control metrics. Independent verification is the cornerstone of reliable preclinical research.

Red Flag 1: Lack of Lot-Specific COAs. Suppliers that provide a static, single Certificate of Analysis for all production runs are not performing batch-level testing. Every vial batch should feature an accessible COA detailing exact purity percentage.

Red Flag 2: Missing Mass Spectrometry Data. HPLC alone confirms chemical purity by peak area, but Mass Spectrometry (MS) is necessary to verify exact molecular weight and sequence identity. Always demand dual HPLC/MS documentation.

Red Flag 3: Unverified Endotoxin Levels. Cell culture and animal model assays are highly sensitive to lipopolysaccharide contamination. Research-grade suppliers must quantify endotoxin levels (EU/mg) via chromogenic LAL testing to ensure biological safety in vitro.

Red Flag 4: Consumer Health or Therapeutic Claims. Companies marketing peptides with dosage guidelines for human consumption violate regulatory standards and signal unvetted, non-compliant supply chains. Legitimate vendors restrict materials strictly to laboratory research use.

Complementary research targets in metabolic and cell signaling studies

Laboratories investigating cellular regeneration, mitochondrial stability, and anabolic signaling pathways often examine multiple peptide targets concurrently to map intersecting cellular pathways.

In addition to evaluating flgr-242 vs alpha-klotho, investigators frequently incorporate mitochondrial-derived peptides like MOTS-c peptide or mitochondrial targeted compounds like SS-31 research peptide into broader cellular stress and metabolism panels.

For full analytical protocols, chemical structures, and peer-reviewed literature summaries, scientists can consult the PX1 Research library for updated technical guides.

Ordering FLGR-242 and Alpha-Klotho from PX1 Research

PX1 Research delivers standardized, research-grade peptides engineered specifically for qualified academic, clinical, and industrial research institutions. When your laboratory orders from PX1 Research, every shipment includes lyophilized peptide vials sealed under inert gas to prevent oxidation.

Orders are fulfilled directly from our modern domestic facilities in California and Arizona. Orders placed before 1:00 PM PST Monday through Friday feature same-day dispatch with fully tracked domestic express shipping.

Every batch of FLGR-242 and Alpha-Klotho undergoes independent third-party testing in the USA, confirming chemical identity via MS, analytical purity via HPLC (guaranteed >98%), and strict endotoxin limits. Certificates of Analysis for your specific lot are accessible directly on our platform.

For technical inquiries, bulk packaging requests, or institutional purchasing orders, explore our bulk research peptide ordering portal or contact our dedicated laboratory support team. Secure your compound supply today through the direct PX1 Research catalog.

Frequently Asked Questions

Is FLGR-242 or Alpha-Klotho approved for human use?

No. Neither compound is approved for human consumption, clinical treatment, or therapeutic use. Both FLGR-242 and Alpha-Klotho are strictly synthesized and supplied for laboratory in vitro and preclinical research applications.

What is the key functional difference when comparing flgr-242 vs alpha-klotho?

FLGR-242 acts as a specific synthetic modulator of TGF-beta family pathways such as myostatin, whereas Alpha-Klotho is a membrane-bound co-receptor and circulating enzyme involved in FGF23 signaling, phosphate regulation, and oxidative stress pathways.

Do you provide a COA for my specific lot of FLGR-242 or Alpha-Klotho?

Yes. PX1 Research provides lot-specific Certificates of Analysis with every shipment. Each COA documents third-party HPLC purity, mass spectrometry sequence confirmation, and endotoxin assay results.

How fast does PX1 Research ship peptide orders?

Orders placed before 1:00 PM PST Monday through Friday ship same-day from our fulfillment facilities in California and Arizona, complete with domestic transit tracking.

What purity level is guaranteed for these research peptides?

PX1 Research guarantees a minimum analytical purity of 98% for both FLGR-242 and Alpha-Klotho as verified by third-party High-Performance Liquid Chromatography (HPLC).

How should reconstituted FLGR-242 be stored in the lab?

Once reconstituted with sterile laboratory water or buffer, FLGR-242 should be divided into single-use aliquots and stored at -20°C or -80°C to preserve structural stability and minimize freeze-thaw degradation.

Are these peptides manufactured in the USA?

Yes. PX1 Research utilizes strictly verified USA synthesis protocols and domestic third-party analytical testing facilities to ensure consistent quality control and purity.

Can I order FLGR-242 and Alpha-Klotho in bulk for large experimental runs?

Yes. Institutional buyers and research facilities can request custom vial sizes, bulk quantities, or specialized packaging options through the PX1 Research wholesale portal.

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.